UNSPSC 51201652: SARS COV-2 coronavirus vaccine

In November 2021, the WHO licensed the vaccines from Pfizer / BioNTech, AstraZeneca / Oxford, Janssen, Moderna, Sinopharm, Sinovac and Bharat. Other vaccines continue to be studied. Additionally, national regulatory agencies (RNAs) have licensed other COVID-19 vaccines in specific countries.

UNSPSC 51201652 SARS COV-2 coronavirus vaccine is a Commodity code under which state and local health departments procure vaccines and immunological products. The code's nominal scope — COVID-19 vaccines — has shifted in recent procurement activity; the single recent state-local opportunity shows health departments now using this code to solicit vaccines outside the COVID-19 family, including Yellow Fever vaccine. The Mississippi State Department of Health posted a sole source procurement notice for Yellow Fever Vaccine from Sanofi Pasteur, Inc. in July 2026, indicating that state health departments are applying this code to routine immunization supply procurement rather than pandemic response. Issuing bodies under this code are state-level health departments; the Mississippi notice is the only recent activity visible in the current opportunity stream.

The Mississippi State Department of Health's Yellow Fever Vaccine sole source notice posted July 13, 2026, with an objection deadline of August 3, 2026 at 10:00 a.m. CST directed to Cynthia Brasher (Cynthia.brasher@msdh.ms.gov). The notice does not specify quantity, contract term, estimated value, or pricing. The procurement permits any entity to object to the sole source designation by submitting written notice with detailed explanation and supporting documentation demonstrating that an alternative vendor can supply the vaccine; if substantiated objections are received, the department will conduct a competitive bid process. Geographic activity under this code is currently limited to Mississippi based on recent posting activity.